Page 101 - Read Online

in remitting childhood absence epilepsy. Am J Hum Genet with Stiff‑man syndrome, epilepsy, and type I diabetes mellitus. N Engl
2008;82:1249‑61. J Med 1988;318:1012‑20.
30. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. 48. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA,
Epilepsia 1995;36 Suppl 2:S2‑12. Ahlskog JE, Pittock SJ. Stiff‑man syndrome and variants: clinical
31. Gonzalez MI. The possible role of GABAA receptors and gephyrin in course, treatments, and outcomes. Arch Neurol 2012;69:230‑8.
epileptogenesis. Front Cell Neurosci 2013;7:113. 49. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan
32. Ohkawa T, Satake S, Yokoi N, Miyazaki Y, Ohshita T, Sobue G, CL, Kim KK, Kilimann MW, Lennon VA. Amphiphysin autoimmunity:
Takashima H, Watanabe O, Fukata Y, Fukata M. Identification and paraneoplastic accompaniments. Ann Neurol 2005;58:96‑107.
characterization of GABA(A) receptor autoantibodies in autoimmune 50. Baizabal‑Carvallo JF, Jankovic J. Stiff‑person syndrome: insights
encephalitis. J Neurosci 2014;34:8151‑63. into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry
33. Petit‑Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, 2015;86:840‑8.
McCracken L, Martinez‑Hernandez E, Mason WP, Kruer MC, Ritacco 51. Pleasure D. GlyRalpha1, GAD65, amphiphysin, and gephyrin
DG, Grisold W, Meaney BF, Alcala C, Sillevis‑Smitt P, Titulaer MJ, autoantibodies: leading or supporting roles in stiff‑person disorders?
Balice‑Gordon R, Graus F, Dalmau J. Encephalitis with refractory JAMA Neurol 2013;70:16‑7.
seizures, status epilepticus, and antibodies to the GABAA receptor: a 52. Woodhall M, Coban A, Waters P, Ekizoglu E, Kurtuncu M, Shugaiv E,
case series, characterisation of the antigen, and analysis of the effects Turkoglu R, Akman‑Demir G, Eraksoy M, Vincent A, Tuzun E. Glycine
of antibodies. Lancet Neurol 2014;13:276‑86. receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish
34. Benarroch EE. Glycine and its synaptic interactions: functional and patients with neuromyelitis optica. J Neurol Sci 2013;335:221‑3.
clinical implications. Neurology 2011;77:677‑83. 53. Martinez‑Hernandez E, Sepulveda M, Rostasy K, Hoftberger R,
35. Martinez‑Martinez P, Molenaar PC, Losen M, de Baets MH. Graus F, Harvey RJ, Saiz A, Dalmau J. Antibodies to aquaporin
Glycine receptor antibodies in PERM: a new channelopathy. Brain 4, myelin‑oligodendrocyte glycoprotein, and the glycine receptor
2014;137:2115‑6. alpha1 subunit in patients with isolated optic neuritis. JAMA Neurol
36. Chung SK, Vanbellinghen JF, Mullins JG, Robinson A, Hantke J, 2015;72:187‑93.
Hammond CL, Gilbert DF, Freilinger M, Ryan M, Kruer MC, Masri A, 54. Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S, Bebek
Gurses C, Ferrie C, Harvey K, Shiang R, Christodoulou J, Andermann N, Gurses C, Gokyigit A, Waters P, Vincent A, Baykan B. Investigation
F, Andermann E, Thomas RH, Harvey RJ, Lynch JW, Rees MI. of neuronal autoantibodies in two different focal epilepsy syndromes.
Pathophysiological mechanisms of dominant and recessive GLRA1 Epilepsia 2014;55:414‑22.
mutations in hyperekplexia. J Neurosci 2010;30:9612‑20. 55. Turner MR, Irani SR, Leite MI, Nithi K,Vincent A, Ansorge O.
37. Legendre P. The glycinergic inhibitory synapse. Cell Mol Life Sci Progressive encephalomyelitis with rigidity and myoclonus: glycine
2001;58:760‑93. and NMDA receptor antibodies. Neurology 2011;77:439‑43.
38. Waldvogel HJ, Baer K, Eady E, Allen KL, Gilbert RT, Mohler 56. Stern WM, Howard R, Chalmers RM, Woodhall MR, Waters P,
H, Rees MI, Nicholson LF, Faull RL. Differential localization of Vincent A, Wickremaratchi MM. Glycine receptor antibody mediated
gamma‑aminobutyric acid type A and glycine receptor subunits and Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM): a
gephyrin in the human pons, medulla oblongata and uppermost rare but treatable neurological syndrome. Pract Neurol 2014;14:123‑7.
cervical segment of the spinal cord: an immunohistochemical study. J 57. Derksen A, Stettner M, Stocker W, Seitz RJ. Antiglycine receptor‑related
Comp Neurol 2010;518:305‑28. stiff limb syndrome in a patient with chronic lymphocytic leukaemia.
39. Carvajal‑Gonzalez A, Leite MI, Waters P, Woodhall M, Coutinho BMJ Case Rep 2013;doi: 10.1136/bcr‑2013‑008667.
E, Balint B, Lang B, Pettingill P, Carr A, Sheerin UM, Press R, 58. Kyskan R, Chapman K, Mattman A, Sin D. Antiglycine receptor
Lunn MP, Lim M, Maddison P, Meinck HM, Vandenberghe W, antibody and encephalomyelitis with rigidity and myoclonus (PERM)
Vincent A. Glycine receptor antibodies in PERM and related related to small cell lung cancer. BMJ Case Rep 2013;doi: 10.1136/
syndromes: characteristics, clinical features and outcomes. Brain bcr‑2013‑010027.
2014;137:2178‑92. 59. Zuliani L, Ferlazzo E, Andrigo C, Casano A, Cianci V, Zoccarato M,
40. Butler MH, Hayashi A, Ohkoshi N, Villmann C, Becker CM, Feng G, Leite MI, Waters P, Woodhall M, Della Mora E, Morra M, Giometto
De Camilli P, Solimena M. Autoimmunity to gephyrin in Stiff‑man B, Aguglia U, Vincent A. Glycine receptor antibodies in 2 cases of
syndrome. Neuron 2000;26:307‑12. new, adult‑onset epilepsy. Neurol Neuroimmunol Neuroinflamm
41. Hutchinson M, Waters P, McHugh J, Gorman G, O’Riordan S, 2014;1:e16.
Connolly S, Hager H, Yu P, Becker CM, Vincent A. Progressive 60. Clerinx K, Breban T, Schrooten M, Leite MI, Vincent A, Verschakelen
encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor J, Tousseyn T, Vandenberghe W. Progressive encephalomyelitis with
antibody. Neurology 2008;71:1291‑2. rigidity and myoclonus: resolution after thymectomy. Neurology
42. McKeon A, Martinez‑Hernandez E, Lancaster E, Matsumoto JY, 2011;76:303‑4.
Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J. Glycine 61. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C,
receptor autoimmune spectrum with Stiff‑man syndrome phenotype. Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez‑Hernandez
JAMA Neurol 2013;70:44‑50. E, Aguilar E, Gresa‑Arribas N, Ryan‑Florance N, Torrents A, Saiz A,
43. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and Rosenfeld MR, Balice‑Gordon R, Graus F, Dalmau J. Treatment and
spasm (“stiff‑man” syndrome); report of a case and some observations prognostic factors for long‑term outcome in patients with anti‑NMDA
in 13 other cases. Proc Staff Meet Mayo Clin 1956;31:421‑7. receptor encephalitis: an observational cohort study. Lancet Neurol
44. Molina JA, Porta J, Garcia‑Morales I, Bermejo PF, Jimenez‑Jimenez 2013;12:157‑65.
FJ. Treatment with intravenous prednisone and immunoglobin in a 62. Zuliani L, Graus F, Giometto B, Bien C, Vincent A. Central nervous
case of progressive encephalomyelitis with rigidity. J Neurol Neurosurg system neuronal surface antibody associated syndromes: review
Psychiatry 2000;68:395‑6. and guidelines for recognition. J Neurol Neurosurg Psychiatry
45. Whiteley AM, Swash M, Urich H. Progressive encephalomyelitis with 2012;83:638‑45.
rigidity. Brain 1976;99:27‑42. 63. Toledano M, Britton JW, McKeon A, Shin C, Lennon VA, Quek AM,
46. Campbell AM, Garland H. Subacute myoclonic spinal neuronitis. J So E, Worrell GA, Cascino GD, Klein CJ, Lagerlund TD, Wirrell
Neurol Neurosurg Psychiatry 1956;19:268‑74. EC, Nickels KC, Pittock SJ. Utility of an immunotherapy trial in
47. Solimena M, Folli F, Denis‑Donini S, Comi GC, Pozza G, De Camilli P, evaluating patients with presumed autoimmune epilepsy. Neurology
Vicari AM. Autoantibodies to glutamic acid decarboxylase in a patient 2014;82:1578‑86.

92 Neuroimmunol Neuroinfammation | Volume 3 | March 28, 2016